Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus
- 1 January 1995
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 98 (1) , 32-41
- https://doi.org/10.1016/s0002-9343(99)80078-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Plasmapheresis in LupusLupus, 1993
- Central nervous system systemic lupus erythematosus mimicking progressive multifocal leucoencephalopathy.Annals of the Rheumatic Diseases, 1992
- Pulse Cyclophosphamide for Severe Neuropsychiatric LupusQJM: An International Journal of Medicine, 1991
- Clinical and Immunologic Effects of Monthly Administration of Intravenous Cyclophosphamide in Severe Systemic Lupus ErythematosusNew England Journal of Medicine, 1988
- High‐dose intravenous cyclophosphamide treatment of systemic lupus erythematosus‐associated aplastic anemiaArthritis & Rheumatism, 1988
- Association between Lupus Psychosis and Antiribosomal P Protein AntibodiesNew England Journal of Medicine, 1987
- Therapy of Lupus NephritisNew England Journal of Medicine, 1986
- Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunctionThe American Journal of Medicine, 1983
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982
- Reversal of aplastic anaemia secondary to systemic lupus erythematosus by high-dose intravenous cyclophosphamideBMJ, 1982